trending Market Intelligence /marketintelligence/en/news-insights/trending/mhz6zz6kviwqpgdhxp3bvq2 content esgSubNav
In This List

Affimed appoints chief medical officer

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Affimed appoints chief medical officer

Affimed NV named Leila Alland as its chief medical officer, effective March 26.

Alland was most recently the chief medical officer of Tarveda Therapeutics Inc., a Watertown, Mass.-based developer of drug candidates that target solid tumors.

Prior to joining Tarveda, she was with AstraZeneca PLC as vice president and head of oncology for early clinical development.

Germany-based Affimed works to discover and develop cancer immunotherapies.